分子影像市場：按產品類型、軟體平台、應用、最終用戶和地區分類

預計 2025 年全球分子影像市場規模為 53.2 億美元，到 2032 年將達到 77.9 億美元，2025 年至 2032 年的複合年成長率為 5.6%。

分子影像是醫學影像的一個分支，專注於對活體患者體內的醫學相關分子進行成像。分子成像技術是一種融合分子生物學和細胞生物學的先進成像技術。它是一種安全、非侵入性、無痛的治療方法，用於診斷和治療多種疾病，包括心血管疾病、神經系統疾病、腫瘤疾病、呼吸系統疾病和胃腸道疾病。分子影像是核子醫學的一個分支，使用少量放射性物質（放射性藥物）來診斷和治療疾病。此外，分子影像還能幫助醫生管理疾病並提供個人化的病患照護。

市場動態

分子影像技術已成為各類癌症的標準治療方法。影像技術在早期癌症檢測、療效評估和新治療方法研發中的應用日益廣泛，對癌症的臨床管理產生了顯著影響。因此，人們對早期診斷的認知不斷提高，可能會推動對正子斷層掃描 (PET)、單光子發射電腦斷層掃描 (SPECT)、正子斷層掃描-電腦斷層掃描 (PET-CT) 和單光子發射電腦斷層掃描-電腦斷層掃描 (SPECT-CT) 等診斷產品的需求。預計這將推動全球分子成像市場的成長。此外，技術先進產品的快速普及也有望推動市場成長。例如，2021年6月，領先的診斷影像系統供應商佳能醫療系統美國公司（Canon Medical Systems USA Inc.）憑藉其Cartesion Prime數位PET/CT系統中採用的深度學習重建（DLR）技術和高級智慧Clear-IQ引擎（AiCE）獲得了美國食品藥物管理局（FDA）的510(k)許可。由AiCE支持的Cartesion Prime使臨床醫生能夠每天獲得一致、高品質的影像。

本報告的主要特點

• 本報告對全球分子成像市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和複合年成長率。
• 它還強調了每個細分市場的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
• 全球分子成像市場的主要企業是根據以下參數列出的，例如公司概況、產品系列、主要亮點、財務表現和策略。
• 透過本報告的見解，負責人和企業經營團隊可以就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
• 「全球分子成像市場」報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
• 相關人員可以透過用於分析全球分子成像市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 分析目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map (COM)

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 主要亮點
• 流行病學
• 企業合併、商業合作
• 監管情景
• 主要進展
• PEST分析

第4章 全球分子影像市場：COVID-19感染疾病的影響

• COVID-19流行病學
• 供需側分析
• 經濟影響

第5章全球分子影像市場依產品類型（2020-2032）

• 裝置
• 軟體平台

6. 全球分子影像市場應用（2020-2032）

• 心血管系統
• 神經病學
• 腫瘤學
• 呼吸系統
• 胃腸道
• 其他用途

7. 全球分子影像市場（依最終用戶分類）（2020-2032）

• 醫院
• 診斷影像中心
• 門診手術中心

8. 全球分子影像市場（按地區）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 中東
  • GCC
  • 以色列
  • 其他中東地區
• 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭態勢

• 公司簡介
  • GE Healthcare
  • Bruker Corporation
  • Fujifilm Holdings Corp.
  • Siemens Healthineers
  • Koninklijke Philips NV
  • Canon Medical Systems Corporation
  • United Imaging Healthcare Co., Ltd.
  • Mediso Kft.
  • Positron Corporation
  • Esaote SpA
  • Carestream Health
  • Mirada Medical Limited
  • Hermes Medical Solutions

第 10 章 章節

• 參考
• 分析方法

Global molecular imaging market is estimated to be valued at USD 5.32 Bn in 2025 and is expected to reach USD 7.79 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.

Molecular imaging is an area of medical imaging that focuses on imaging molecules of medical concern in living patients. It is integrated advanced imaging technology with molecular and cellular biology. It is safe, noninvasive, and painless procedure that is used to diagnose and manage a wide range of diseases such as cardiovascular, neurology, oncology, respiratory, and gastrointestinal. Molecular imaging is field of nuclear medicine. It includes small amount of radioactive materials (radiopharmaceuticals) to diagnose and treat disease. Moreover, molecular imaging helps to physician to disease management and improve personalize patient care.

Market Dynamics

Molecular imaging has become a part of the standard care for various types of cancer. The use of imaging techniques in early cancer detection, treatment response, and new therapy development is steadily growing and has significantly impacted the clinical management of cancer. Thus, increasing awareness of the early diagnosis is likely to boost the demand for diagnostic products such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), positron emission tomography-computed tomography (PET-CT), single-photon emission computed tomography-computed tomography (SPECT-CT), etc. This, in turn, is expected to drive the global molecular imaging market growth. Moreover, a surge in the adoption of technologically advanced products is expected to drive the market growth. For instance, in June 2021, a leading provider of diagnostic imaging systems Canon Medical Systems USA Inc. a leading provider of diagnostic imaging systems, deep Learning Reconstruction (DLR) technology and Advanced intelligent Clear-IQ Engine (AiCE), both used in Cartesion Prime Digital PET/CT system, received 510(k) clearance from the U.S. Food and Drugs Administration (FDA). The Cartesion Prime with AiCE help clinicians consistently and routinely produce high-quality images.

Key features of the study:

• This report provides an in-depth analysis of the global molecular imaging market, market size (US$ Bn), and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global molecular imaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies.
• Key companies covered as a part of this study include GE Healthcare, Bruker Corporation, Fujifilm Holdings Corp., Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, UNITED IMAGING HEALTHCARE CO., LTD., Mediso kft., Positron Corporation, ESAOTE S.P.A., Carestream Health, Mirada Medical Limited, and Hermes Medical Solutions
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global molecular imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular imaging market.

Market Segmentation

• Global Molecular Imaging Market, By Product Type
  • Devices
  • Molecular Ultrasound Imaging
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Nuclear Magnetic Resonance (NMR) Spectrometer
  • Hybrid Products
  • Positron Emission Tomography- Computed Tomography (PET-CT)
  • Positron Emission Tomography- Magnetic Resonance (PET-MR)
  • Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
  • Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
  • Software Platforms
  • On Premises Solutions
  • Cloud Based Solutions
• Global Molecular Imaging Market, By Application:
  • Cardiovascular
  • Neurology
  • Oncology
  • Respiratory
  • Gastrointestinal
  • Other Applications
• Global Molecular Imaging Market, By End User
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
• Global Molecular Imaging Market, By Region:
  • North America
  • By Product Type
  • Devices
  • Molecular Ultrasound Imaging
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Nuclear Magnetic Resonance (NMR) Spectrometer
  • Hybrid Products
  • Positron Emission Tomography - Computed Tomography (PET-CT)
  • Positron Emission Tomography - Magnetic Resonance (PET-MR)
  • Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
  • Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
  • Software Platforms
  • On Premises Solutions
  • Cloud Based Solutions
  • By Application
  • Cardiovascular
  • Neurology
  • Oncology
  • Respiratory
  • Gastrointestinal
  • Other Applications
  • By End User
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Product Type
  • Devices
  • Molecular Ultrasound Imaging
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Nuclear Magnetic Resonance (NMR) Spectrometer
  • Hybrid Products
  • Positron Emission Tomography - Computed Tomography (PET-CT)
  • Positron Emission Tomography - Magnetic Resonance (PET-MR)
  • Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
  • Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
  • Software Platforms
  • On Premises Solutions
  • Cloud Based Solutions
  • By Application
  • Cardiovascular
  • Neurology
  • Oncology
  • Respiratory
  • Gastrointestinal
  • Other Applications
  • By End User
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Product Type
  • Devices
  • Molecular Ultrasound Imaging
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Nuclear Magnetic Resonance (NMR) Spectrometer
  • Hybrid Products
  • Positron Emission Tomography - Computed Tomography (PET-CT)
  • Positron Emission Tomography - Magnetic Resonance (PET-MR)
  • Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
  • Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
  • Software Platforms
  • On Premises Solutions
  • Cloud Based Solutions
  • By Application
  • Cardiovascular
  • Neurology
  • Oncology
  • Respiratory
  • Gastrointestinal
  • Other Applications
  • By End User
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product Type
  • Devices
  • Molecular Ultrasound Imaging
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Nuclear Magnetic Resonance (NMR) Spectrometer
  • Hybrid Products
  • Positron Emission Tomography - Computed Tomography (PET-CT)
  • Positron Emission Tomography - Magnetic Resonance (PET-MR)
  • Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
  • Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
  • Software Platforms
  • On Premises Solutions
  • Cloud Based Solutions
  • By Application
  • Cardiovascular
  • Neurology
  • Oncology
  • Respiratory
  • Gastrointestinal
  • Other Applications
  • By End User
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Product Type
  • Devices
  • Molecular Ultrasound Imaging
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Nuclear Magnetic Resonance (NMR) Spectrometer
  • Hybrid Products
  • Positron Emission Tomography - Computed Tomography (PET-CT)
  • Positron Emission Tomography - Magnetic Resonance (PET-MR)
  • Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
  • Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
  • Software Platforms
  • On Premises Solutions
  • Cloud Based Solutions
  • By Application
  • Cardiovascular
  • Neurology
  • Oncology
  • Respiratory
  • Gastrointestinal
  • Other Applications
  • By End User
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product Type
  • Devices
  • Molecular Ultrasound Imaging
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Nuclear Magnetic Resonance (NMR) Spectrometer
  • Hybrid Products
  • Positron Emission Tomography - Computed Tomography (PET-CT)
  • Positron Emission Tomography - Magnetic Resonance (PET-MR)
  • Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
  • Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
  • Software Platforms
  • On Premises Solutions
  • Cloud Based Solutions
  • By Application
  • Cardiovascular
  • Neurology
  • Oncology
  • Respiratory
  • Gastrointestinal
  • Other Applications
  • By End User
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • GE Healthcare
  • Bruker Corporation
  • Fujifilm Holdings Corp.
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • UNITED IMAGING HEALTHCARE CO., LTD.
  • Mediso kft.
  • Positron Corporation
  • ESAOTE S.P.A.
  • Carestream Health
  • Mirada Medical Limited
  • Hermes Medical Solutions

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Test Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Molecular Imaging Market - COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Molecular Imaging Market, By Product Type, 2020- 2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
    • Molecular Ultrasound Imaging
    • Positron Emission Tomography (PET)
    • Single Photon Emission Computed Tomography (SPECT)
    • Nuclear Magnetic Resonance (NMR) Spectrometer
    • Hybrid Products ( Positron Emission Tomography - Computed Tomography (PET-CT)
    • Positron Emission Tomography- Magnetic Resonance (PET-MR)
    • Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
    • Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR))
• Software Platforms
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
    • On Premises Solutions
    • Cloud Based Solutions

6. Global Molecular Imaging Market, By Application, 2020 - 2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
• Respiratory
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
• Gastrointestinal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
• Other Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends

7. Global Molecular Imaging Market, By End User, 2020 - 2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Diagnostic Imaging Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Others

8. Global Molecular Imaging Market, By Region, 2020 - 2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Region/Country, 2020 -2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • GE Healthcare
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Bruker Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Fujifilm Holdings Corp.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Siemens Healthineers
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Koninklijke Philips N.V.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Canon Medical Systems Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • United Imaging Healthcare Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Mediso Kft.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Positron Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Esaote SpA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Carestream Health
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Mirada Medical Limited
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Hermes Medical Solutions
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies

10. Section

• References
• Research Methodology
• About us and Sales Contact